•         

Oncology(CE)

Advancing Precision Oncology through High-Resolution Capillary Electrophoresis-Based Fragment Analysis

The era of precision oncology emphasizes treatment strategies tailored to the genetic features of each tumor. Molecular profiling enables researchers to explore genetic mutations, microsatellite instability (MSI), and pharmacogenomic markers associated with tumor behavior and drug response. These insights lay the foundation for developing targeted therapies and improving patient outcomes.

Scientist analyzing DNA gel electrophoresis

CE Fragment Analysis in Cancer Research

Capillary electrophoresis (CE) combined with fluorescent fragment analysis is a widely adopted method in molecular oncology research. It provides high sensitivity and reproducibility for detecting size-based DNA variations such as microsatellite instability, short insertions/deletions, and repeat expansions. Compared to other platforms, CE fragment analysis offers a streamlined, cost-effective solution well-suited for:

  • MSI status investigation in colorectal and endometrial cancer studies
  • Detection of PMS2 and PMS2CL genes variants by length difference analysis
  • Allelic imbalance and LOH (Loss of Heterozygosity) studies

CT scan contrast imaging procedure start

What Researchers Value

Researchers working with CE test kits for oncology often seek:

  • Reliable, high-resolution results for detecting subtle size variations
  • Flexible, user-friendly workflows that integrate with existing lab platforms
  • Low input requirements, ideal for FFPE and biopsy-derived DNA
  • Clear data analysis tools for interpreting fragment profiles

CD Genomics' CE platforms and kits deliver exceptional resolution for subtle size variations, flexible workflows for seamless integration, minimal sample input (FFPE-friendly), and intuitive software for complex fragment analysis.

* For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.

Explore Our Oncology(CE):

Cat. No. Product Name Brief Description Inquiry Basket
PCO001 CDCep™ MSI test Kit Evaluate microsatellite instability with the CDCep™ MSI Test Kit. Get precise MSI status in tumor DNA for oncology research. Learn more today.
PCO002 CDCep™ BRCA1/2 MLPA test Kit Detect BRCA1/2 large genomic rearrangements with the CDCep™ BRCA1/2 MLPA Test Kit. Ensure accurate hereditary cancer screening. Learn more today.
Copyright © 2026 CD Genomics. All rights reserved.
Top
0
Inquiry Basket